Study: Flu vaccine is money loser for doctors paid by Medicaid

NewsGuard 100/100 Score
More poor children would get the flu vaccine if Medicaid increased the reimbursement to doctors for giving the shot, according to a new study published in the journal Pediatrics.

"Researchers at the University of Rochester Medical Center (URMC) looked at U.S. flu immunization rates for children between the ages of 6 months and 23 months during the 2005-2006, 2006-2007 and 2007-2008 flu seasons, and found that states with lower Medicaid reimbursement rates had lower vaccination rates," USA Today reports. Reimbursement rates ranged from $2 in Colorado, Connecticut and Hawaii to almost $18 in New York, with the average reimbursement rate $9. In a previous study, the researchers had calculated that the actual cost to doctors' offices for administering a vaccine was $20" (Preidt, 10/19).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Oxford University and Brazil partner to advance malaria vaccine development